Effect of Oculomotor Therapy in Individuals With Convergence Insufficiency

University of Nove de Julho

Status: Not yet enrolling

Conditions: Convergence Insufficiency

Treatments: Other: Oculomotor therapy; Other: No Treatment Added

Study type: Interventional

Funder types: Other

Identifiers

NCT07036263

CI-2025

Details and patient eligibility

About

The aim of this study is to investigate the effect of oculomotor therapy in individuals with ocular convergence insufficiency.

Full description

Seventy participants with convergence insufficiency (CI) will be randomly allocated into two groups: Experimental Group (EG) (n=35) and Control Group (CG) (n=35). The primary outcome will be CI assessed by the convergence test. Secondary outcomes will include quality of life, postural balance, and gait speed. The EG will undergo five sessions of oculomotor therapy (once a week), based on and adapted from the established protocol for CI treatment. Results: Outcomes will be assessed by blinded evaluators at baseline, one week after the end of the treatment, and at 1 and 3 months follow-up. The CG will not receive any intervention. Data will be analyzed using statistical tests with a significance level set at p < 0.05.

Enrollment: 70 estimated patients

Sex: All

Ages: 18 to 60 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Individuals diagnosed with convergence insufficiency (CI);
• Aged between 18 and 60 years;
• Physically active individuals;
• Without cognitive impairments;
• Without vestibular system impairments (e.g., dizziness).

Exclusion criteria

• Diagnosis of neurodegenerative diseases (e.g., Parkinson's, ALS);
• Presence of dementia;
• History of stroke;
• Presence of vestibular disorders;
• Systemic neuromuscular diseases;
• Disabling musculoskeletal pain;
• Diagnosis of diabetic polyneuropathy;
• Use of joint prostheses;
• Ongoing physical therapy treatment;
• Lack of physical ability to perform the prescribed physical activities.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

70 participants in 2 patient groups

Experimental Group (EG)

Experimental group

Description:

This group will receive treatment with oculomotor therapy

Treatment:

Other: Oculomotor therapy

Control group (CG)

Other group

Description:

This group will not receive any type of treatment

Treatment:

Other: No Treatment Added